Kindeva Drug Delivery appoints Denis Johnson as COO
Kindeva Drug Delivery (Kindeva), a global leader in drug-device combination products, yesterday announced that Denis Johnson has joined the company as its new Chief Operating Officer (COO). Denis joins Kindeva to lead global operations for all Kindeva’s state-of-the-art manufacturing, research, and development facilities located across the U.S. and U.K. As COO, he will be dedicated to global operations, but […]
KBI Biopharma appoints Peter Carbone as Chief Quality Officer
KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and cGMP contract development and manufacturing organization (CDMO), yesterday announced the appointment of Peter Carbone as the new Chief Quality Officer, strengthening KBI’s expertise in Quality and Regulatory Affairs. A highly respected and successful industry leader, Peter brings over 35 years of experience in operations, quality, […]
STEMCELL Technologies to acquire all assets of SQZ Biotechnologies Company
STEMCELL Technologies announced the acquisition of substantially all assets of SQZ Biotechnologies Company (SQZ)—a Massachusetts-based biotech known for its game-changing method of introducing a variety of therapeutic cargo into cells by squeezing them (mechanoporation) rather than using electricity (electroporation). This transaction, which was approved by SQZ shareholders today, marks another significant milestone for STEMCELL, Canada’s […]
Lysando adds Dr. Holger Zimmermann to its advisory board
Lysando, a leading innovator in the fight against antibiotic-resistant bacteria, announced the appointment of Dr. Holger Zimmermann to its Advisory Board. Dr. Zimmermann’s distinguished career in the pharmaceutical sector and healthcare industry brings a wealth of experience, positioning him as a key asset in Lysando’s mission to eliminate the fear of harmful bacteria worldwide. Currently […]
Sofinnova Partners secures USD 200Mln digital medicine fund
Sofinnova Partners, a leading European life sciences venture capital firm based in Paris, London, and Milan, announced the successful close of Sofinnova Digital Medicine I at $200 million (€190M), significantly exceeding its target. The fund, spearheaded by Partners Edward Kliphuis and Simon Turner, is dedicated to backing pioneering entrepreneurs navigating the convergence of biology, data, […]
Lucid Scientific raises USD 7Mln series A financing
Lucid Scientific, a life science instruments company that manufactures Resipher, announced the completion of a $7 million Series A financing led by IAG Capital Partners. Additional participants include Lucid’s original investor base, the Georgia Research Alliance’s Venture Fund, and Dynamk Capital, bringing Lucid’s total funding to date to approximately $13 million. Proceeds from this round […]
SK Capital announces the completion of strategic investment in Ecopol
Ecopol S.p.A. (“Ecopol” or the “Company”), a leading developer and producer of innovative biodegradable films and delivery systems, announced today the completion of a strategic investment from affiliates of SK Capital Partners, LP (“SK Capital”), a leading private investment firm focused on the specialty materials, ingredients, and life sciences sectors. SK Capital has acquired a […]
KBI Biopharma and Selexis SA announces J.D. Mowery as CEO
KBI Biopharma, Inc. (KBI) and Selexis SA, both JSR Life Sciences companies, recently announced the appointment of J.D. Mowery as Chief Executive Officer (CEO). Widely respected as an innovative biotech leader with a nearly 25-year track record of successfully inspiring colleagues and building organizations, J.D. will lead KBI and Selexis into the next chapter of […]
Cognizant collaborates with Boehringer Ingelheim to accelerate the medicinal therapies development
Cognizant announced it is working with Boehringer Ingelheim, one of the leading research-driven biopharmaceutical company, to advance the speed and quality of medicinal therapy development. Leveraging the Veeva Development Cloud, Cognizant will help Boehringer Ingelheim to unify medicinal development processes and data into a connected technology ecosystem, enhancing collaboration across clinical, regulatory, and quality functions. “Achieving […]
Global Prairie announces Partnership with Hileman Group
Global Prairie, One of the employee-owned international marketing consultancy, announces its merger with Hileman Group, One of the fast-growing marketing technology firm serving leading healthcare, life sciences, higher education, consumer packaged goods, manufacturing, and FinTech organizations. The merger will enable Global Prairie to drive greater impact for its clients,amplifying organizational purpose with data-driven strategies and […]
